Terms: = Colorectal cancer AND STAT6, D12S1644, 6778, ENSG00000166888, IL-4-STAT, P42226, STAT6B, STAT6C AND Treatment
12 results:
1. Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity.
Li Y; Shen Z; Chai Z; Zhan Y; Zhang Y; Liu Z; Liu Y; Li Z; Lin M; Zhang Z; Liu W; Guan S; Zhang J; Qian J; Ding Y; Li G; Fang Y; Deng H
Gut; 2023 Nov; 72(12):2307-2320. PubMed ID: 37507218
[TBL] [Abstract] [Full Text] [Related]
2. Targeting Erbin in B cells for therapy of lung metastasis of colorectal cancer.
Shen T; Liu JL; Wang CY; Rixiati Y; Li S; Cai LD; Zhao YY; Li JM
Signal Transduct Target Ther; 2021 Mar; 6(1):115. PubMed ID: 33707428
[TBL] [Abstract] [Full Text] [Related]
3. Use of stat6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis.
Mendoza-Rodríguez MG; Sánchez-Barrera CÁ; Callejas BE; García-Castillo V; Beristain-Terrazas DL; Delgado-Buenrostro NL; Chirino YI; León-Cabrera SA; Rodríguez-Sosa M; Gutierrez-Cirlos EB; Pérez-Plasencia C; Vaca-Paniagua F; Meraz-Ríos MA; Terrazas LI
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244885
[TBL] [Abstract] [Full Text] [Related]
4. Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and stat6.
Jiang L; Zhao XH; Mao YL; Wang JF; Zheng HJ; You QS
J Exp Clin Cancer Res; 2019 Nov; 38(1):465. PubMed ID: 31718693
[TBL] [Abstract] [Full Text] [Related]
5. stat6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines.
Salguero-Aranda C; Sancho-Mensat D; Canals-Lorente B; Sultan S; Reginald A; Chapman L
PLoS One; 2019; 14(5):e0207558. PubMed ID: 31075146
[TBL] [Abstract] [Full Text] [Related]
6. An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer.
Bartolomé RA; Jaén M; Casal JI
Br J Cancer; 2018 Oct; 119(8):940-949. PubMed ID: 30318506
[TBL] [Abstract] [Full Text] [Related]
7. Deceleration of glycometabolism impedes IgG-producing B-cell-mediated tumor elimination by targeting SATB1.
Liu J; Li Y; Lu Z; Gu J; Liang Y; Huang E; Wang Z; Zhang H; Wang L; Zhang D; Yu H; Liu R; Chu Y
Immunology; 2019 Jan; 156(1):56-68. PubMed ID: 30171602
[TBL] [Abstract] [Full Text] [Related]
8. Propofol prevents IL-13-induced epithelial-mesenchymal transition in human colorectal cancer cells.
Xu K; Tao W; Su Z
Cell Biol Int; 2018 Aug; 42(8):985-993. PubMed ID: 29569786
[TBL] [Abstract] [Full Text] [Related]
9. Immune checkpoint inhibitors in malignancies with mismatch repair deficiency: a review of the state of the current knowledge.
Naboush A; Roman CA; Shapira I
J Investig Med; 2017 Apr; 65(4):754-758. PubMed ID: 28104820
[TBL] [Abstract] [Full Text] [Related]
10. The involvement of M2 macrophage polarization inhibition in fenretinide-mediated chemopreventive effects on colon cancer.
Dong R; Gong Y; Meng W; Yuan M; Zhu H; Ying M; He Q; Cao J; Yang B
Cancer Lett; 2017 Mar; 388():43-53. PubMed ID: 27913199
[TBL] [Abstract] [Full Text] [Related]
11. Survivin is regulated by interleukin-4 in colon cancer stem cells.
Di Stefano AB; Iovino F; Lombardo Y; Eterno V; Höger T; Dieli F; Stassi G; Todaro M
J Cell Physiol; 2010 Nov; 225(2):555-61. PubMed ID: 20506498
[TBL] [Abstract] [Full Text] [Related]
12. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells.
Murata T; Noguchi PD; Puri RK
J Biol Chem; 1995 Dec; 270(51):30829-36. PubMed ID: 8530527
[TBL] [Abstract] [Full Text] [Related]
